Żelazny, Przemysław, et al. “Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) Therapy As a New Hope in the Population of People With Heart Failure With Reduced Ejection Fraction (HFrEF)”. Journal of Education, Health and Sport, vol. 12, no. 9, Sept. 2022, pp. 583-8, doi:10.12775/JEHS.2022.12.09.068.